Business Description
MediClin AG
ISIN : DE0006595101
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.22 | |||||
Debt-to-Equity | 2.45 | |||||
Debt-to-EBITDA | 4.74 | |||||
Interest Coverage | 2.6 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 1.15 | |||||
Beneish M-Score | -3.08 | |||||
WACC vs ROIC |
Growth Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.4 | |||||
3-Year EBITDA Growth Rate | 9.3 | |||||
3-Year EPS without NRI Growth Rate | -6.6 | |||||
3-Year FCF Growth Rate | -24.2 | |||||
3-Year Book Growth Rate | 3.4 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 59.78 | |||||
9-Day RSI | 59.97 | |||||
14-Day RSI | 59.69 | |||||
6-1 Month Momentum % | -11.54 | |||||
12-1 Month Momentum % | -23.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.75 | |||||
Quick Ratio | 1.71 | |||||
Cash Ratio | 0.67 | |||||
Days Inventory | 33.95 | |||||
Days Sales Outstanding | 45.89 | |||||
Days Payable | 50.92 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -34.06 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.37 | |||||
Operating Margin % | 8.53 | |||||
Net Margin % | -1.48 | |||||
FCF Margin % | 5.54 | |||||
ROE % | -5.14 | |||||
ROA % | -1.19 | |||||
ROIC % | 10.48 | |||||
ROC (Joel Greenblatt) % | 2.88 | |||||
ROCE % | 2.08 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 20.18 | |||||
Price-to-Owner-Earnings | 5.2 | |||||
PS Ratio | 0.18 | |||||
PB Ratio | 0.68 | |||||
Price-to-Tangible-Book | 0.77 | |||||
Price-to-Free-Cash-Flow | 3.3 | |||||
Price-to-Operating-Cash-Flow | 1.71 | |||||
EV-to-EBIT | 32.67 | |||||
EV-to-EBITDA | 4.92 | |||||
EV-to-Revenue | 0.68 | |||||
EV-to-FCF | 12.33 | |||||
Price-to-Projected-FCF | 0.28 | |||||
Price-to-DCF (FCF Based) | 0.23 | |||||
Price-to-Median-PS-Value | 0.54 | |||||
Earnings Yield (Greenblatt) % | 3.06 | |||||
FCF Yield % | 30.18 | |||||
Forward Rate of Return (Yacktman) % | 42.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MediClin AG Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 730.1 | ||
EPS (TTM) (€) | -0.23 | ||
Beta | 0.53 | ||
Volatility % | 8.19 | ||
14-Day RSI | 59.69 | ||
14-Day ATR (€) | 0.118139 | ||
20-Day SMA (€) | 2.572 | ||
12-1 Month Momentum % | -23.84 | ||
52-Week Range (€) | 2.2 - 3.1 | ||
Shares Outstanding (Mil) | 47.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MediClin AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MediClin AG Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
MediClin AG Frequently Asked Questions
What is MediClin AG(STU:MED)'s stock price today?
When is next earnings date of MediClin AG(STU:MED)?
Does MediClin AG(STU:MED) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |